inbiome Overview
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$16M
- Investors
-
7
inbiome General Information
Description
Developer of molecular technology designed for bacterial diagnosis. The company's main offerings include advanced molecular technology for microbiome analysis, which aids in improving the understanding and diagnostics of bacteria in the human body, enabling clients with correct treatments and minimization of unnecessary complications, costs, and antimicrobial resistance.
Contact Information
Website
www.inbiome.comCorporate Office
- Science Park 106
- 1098 XG Amsterdam
- Netherlands
Corporate Office
- Science Park 106
- 1098 XG Amsterdam
- Netherlands
inbiome Timeline
inbiome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 01-Apr-2026 | $16M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | 20-Mar-2024 | Completed | Generating Revenue | |||
| 3. Grant | 01-Oct-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | 01-Jan-2010 | Completed | Generating Revenue |
inbiome Patents
inbiome Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021201675-A1 | Respiratory infectious disease triage | Inactive | 28-Mar-2020 | ||
| US-20230040474-A1 | Methods for identifying microbes in a clinical and non-clinical setting | Pending | 02-Dec-2019 | ||
| WO-2021112673-A1 | Methods for identifying microbes in a clinical and non-clinical setting. | Inactive | 02-Dec-2019 | C12Q1/6809 |
inbiome Signals
inbiome Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NATO Innovation Fund | Venture Capital | Minority | ||
| Slingshot Ventures | Venture Capital | Minority | ||
| Cedars-Sinai Accelerator | Accelerator/Incubator | |||
| ScaleNL | Accelerator/Incubator | |||
| European Innovation Council | Accelerator/Incubator | Minority |
inbiome Investments (1)
inbiome’s most recent deal was a Early Stage VC with Sanome (Decision/Risk Analysis) for . The deal was made on 03-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sanome (Decision/Risk Analysis) | 03-Aug-2021 | Early Stage VC | Decision/Risk Analysis |
inbiome FAQs
-
Where is inbiome headquartered?
inbiome is headquartered in Amsterdam, Netherlands.
-
What is the size of inbiome?
inbiome has 25 total employees.
-
What industry is inbiome in?
inbiome’s primary industry is Diagnostic Equipment.
-
Is inbiome a private or public company?
inbiome is a Private company.
-
What is inbiome’s current revenue?
The current revenue for inbiome is .
-
How much funding has inbiome raised over time?
inbiome has raised $16M.
-
Who are inbiome’s investors?
NATO Innovation Fund, Slingshot Ventures, Cedars-Sinai Accelerator, ScaleNL, and European Innovation Council are 5 of 7 investors who have invested in inbiome.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process